Order results by:
| Issue | Title | |
| Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
| N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
| "... Comorbid patients with atrial fibrillation, diabetes mellitus and chronic kidney disease ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... older (75 vs 72 years, p=0.001), more often had type 2 diabetes mellitus (T2DM) (28.6% vs 20.5%, p=0 ..." | ||
| Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
| "... therapy with the addition of direct oral anticoagulants (DOAC). Material and methods. An open-label ..." | ||
| Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
| S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
| "... to improve the tactics of using direct oral anticoagulants (DOACs) therapy. Clinical situations in which ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... causes of CKD C5 are diabetes mellitus (DM, 46.9%), hypertension (28.8%) and to a lesser extent ..." | ||
| Vol 10, No 3 (2014) | THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW | Abstract similar documents |
| D. A. Napalkov | ||
| "... , myopathy and rhabdomyolysis, the impact on the diabetes and cognitive dysfunction onset, renal function ..." | ||
| Vol 5, No 6 (2009) | INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS | Abstract similar documents |
| A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv | ||
| "... , дилтиазем - в почках. Заключение. Эналаприл снижает содержание вторичных продуктов ПОЛ в тканях почек в ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
| Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
| L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
| "... . Direct oral anticoagulants concentrations were measured using an electrospray ionization mass ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... The current understanding of the management of patients with diabetes mellitus (DM) based ..." | ||
| Vol 17, No 3 (2021) | New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract PDF (Eng) similar documents |
| A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov | ||
| "... , CKD and diabetes mellitus. Material and methods. 60 patients with atrial fibrillation (AF) and CKD ..." | ||
| Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
| A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
| "... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
| Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
| "... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..." | ||
| Vol 16, No 4 (2020) | The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... of type 2 diabetes mellitus and AH dramatically increases the risk of developing terminal stages ..." | ||
| Vol 11, No 2 (2015) | CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION | Abstract similar documents |
| V. N. Shishkova | ||
| Vol 10, No 3 (2014) | ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova | ||
| "... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 hypertensive patients with DM ..." | ||
| Vol 4, No 2 (2008) | COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
| M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva | ||
| "... ) and diabetes mellitus (DM) type 2 after myocardial infarction (MI). Material and methods. 60 patients (45-70 y ..." | ||
| Vol 9, No 4 (2013) | STATINS AND THE RISK OF DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina | ||
| "... the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action ..." | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| "... Aim. To evaluate the effectiveness of the anticoagulant choice algorithm in the prevention ..." | ||
| Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... the efficacy and safety of the use of direct oral anticoagulants (DOACs) in clinical practice. Data on drug ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... Oral anticoagulant therapy is widely used in different patients for the prevention and treatment ..." | ||
| Vol 20, No 3 (2024) | Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase) | Abstract similar documents |
| V. P. Voronina, A. V. Zagrebelny, Yu. V. Lukina, S. N. Tolpygina, N. P. Kutishenko, M. I. Chernysheva, M. M. Lukyanov, N. A. Dmitrieva, O. V. Lerman, S. Yu. Martsevich, O. M. Drapkina | ||
| "... (CVA), and to determine the role of diabetes mellitus (DM) as a possible negative prognostic factor ..." | ||
| Vol 16, No 6 (2020) | Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment | Abstract similar documents |
| V. Yu. Kopylov | ||
| "... into 2 subgroups: patients with stage I chronic heart failure (CHF) without type 2 diabetes mellitus (DM2 ..." | ||
| Vol 17, No 2 (2021) | Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran | Abstract PDF (Eng) similar documents |
| N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev | ||
| "... . The anticoagulant therapy should be prescribed to prevent thromboembolic events. According to randomized clinical ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... Aim. To study the structure of anticoagulant prescription in a general hospital to identify trends ..." | ||
| Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina, B. B. Gegenava | ||
| "... The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... hypertension (HT) combined with type 2 diabetes mellitus (DM). Material and methods. 30 patients with stage ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... in direct oral anticoagulants (DOACs), the possibility of using which in LVT is being actively studied ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... and quality of life of the patient. Anticoagulants, widely used in the treatment of thromboembolic ..." | ||
| Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..." | ||
| Vol 17, No 6 (2021) | Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation | Abstract similar documents |
| T. V. Pavlova | ||
| "... approach to treatment, and their management is a complex clinical task. The direct oral anticoagulant ..." | ||
| Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
| К. V. Lobastov, I. V. Schastlivtsev | ||
| "... (VTE) in cancer patients. In accordance with actual guidelines, the duration of anticoagulant therapy ..." | ||
| Vol 14, No 3 (2018) | THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE | Abstract similar documents |
| I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... hypertrophic cardiomyopathy and diabetes mellitus type 1 in this patient. ..." | ||
| Vol 17, No 1 (2021) | Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction | Abstract similar documents |
| Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya | ||
| "... anticoagulant has unique pharmacologic properties of which clinician should be aware to optimally manage ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... . In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development ..." | ||
| Vol 18, No 5 (2022) | Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
| Z. A. Gebekova, I. I. Ivanov, A. Asambayeva, A. I. Skripka, A. A. Sokolova, D. A. Napalkov, T. A. Vuimo | ||
| "... different direct oral anticoagulants (DOACs) using Thrombodynamics test. Materials and methods ..." | ||
| Vol 15, No 1 (2019) | How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? | Abstract similar documents |
| M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov | ||
| "... The number of elderly patients with diabetes mellitus (DM) is constantly growing in general ..." | ||
| Vol 18, No 4 (2022) | Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants | Abstract similar documents |
| D. V. Pevzner, N. S. Kostritca, A. K. Alieva, I. A. Merkulova, I. S. Yavelov, E. V. Merkulov, I. E. Chazova | ||
| "... anticoagulants (DOACs) or warfarin. Material and methods. A prospective observational study included patients ..." | ||
| Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
| E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
| "... Chronic heart failure (CHF) occurs in 4.3-28% of patients with diabetes mellitus and is most often ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
| T. V. Pavlova | ||
| "... Anticoagulant therapy in elderly patients with atrial fibrillation and concomitant diseases ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... Background. Anticoagulants (AC) are the high-risk drugs. Their safety closely depends on physician ..." | ||
| Vol 12, No 6 (2016) | HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT | Abstract similar documents |
| B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova | ||
| "... of chronic heart failure (CHF) and diabetes mellitus (DM). The modern views on the epidemiology, pathogenesis ..." | ||
| Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
| "... with anticoagulants to prevent an ischemic stroke and systemic thromboembolisms. However, in case of combination AF ..." | ||
| Vol 11, No 4 (2015) | DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY | Abstract similar documents |
| E. B. Akhmedova, B. U. Mardanov, M. N. Mamedov | ||
| "... rhythm disorders, as well as diabetes mellitus (DM) is considered. A significant association between ..." | ||
| Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
| B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
| "... (STEMI) and the features of inpatient treatment in patients with and without diabetes mellitus (DM ..." | ||
| Vol 3, No 2 (2007) | OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina | ||
| "... in patients suffering diabetes mellitus type 2, especially to the role of oxidative stress. It is determined ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... patients with diabetes mellitus (DM) in accordance with target blood pressure (BP) <130/80 mm Hg ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... with persistent nonvalvular atrial fibrillation receiving warfarin and direct oral anticoagulants (DOAC ..." | ||
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| "... В данной статье затрагиваются вопросы применения прямых оральных антикоагулянтов (ПОАК) у ..." | ||
| Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
| N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
| "... ) and venous thromboembolic complications (VTE) should be avoided in favor of safer alternative anticoagulants ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... anticoagulants in comparison with warfarin in a population of patients with atrial fibrillation and chronic ..." | ||
| Vol 20, No 2 (2024) | Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect | Abstract similar documents |
| O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov | ||
| "... ), drugs for type 2 diabetes mellitus treatment, significantly improve metabolic parameters and have ..." | ||
| Vol 20, No 3 (2024) | Theory and practice of selective imidazoline receptor agonist use in Russia | Abstract similar documents |
| N. I. Gaponova, V. R. Abdrakhmanov | ||
| "... in overweight patients, metabolic syndrome, diabetes mellitus, and postmenopausal women is shown. In addition ..." | ||
| Vol 7, No 5 (2011) | CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov | ||
| "... Aim. To study sulodexide clinical efficacy in patients with type 2 diabetes mellitus (DM ..." | ||
| Vol 14, No 5 (2018) | Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov | ||
| "... Obesity is one of the main risk factors for type 2 diabetes developing. The question ..." | ||
| Vol 4, No 2 (2008) | ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008 | Abstract similar documents |
| I. I. Dedov, A. A. Alexanrov | ||
| "... tolerance disturbances including 44% of patient with these reaching the level of diabetes mellitus (DM ..." | ||
| Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
| D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
| "... from hypertension and diabetes mellitus. The patient took bisoprolol, eplerenone, azilsartan medoxomil ..." | ||
| Vol 6, No 6 (2010) | REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" | Abstract similar documents |
| A. A. Aleksandrov | ||
| "... diabetes mellitus is studied insufficiently. Combined therapy with glibenclamide and metformin can result ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... The last decade has dramatically changed the strategy of anticoagulant therapy in patients ..." | ||
| Vol 12, No 4 (2016) | Fighting with obesity: the "gold standard" and new horizons | Abstract similar documents |
| O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov | ||
| "... , such as cardiovascular disease and type 2 diabetes. Therapy aimed at addressing the risk factors of adverse outcomes ..." | ||
| Vol 13, No 1 (2017) | QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov | ||
| "... with HT (I group, n=20; 52.7±9.9 years old); patients with HT and diabetes mellitus (DM) type 2 (II group ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| "... ) or diabetes mellitus (DM) type 2. Material and methods. Patients with HT (2-3 degree) associated with IHD ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... patients initially and 6 months later. Results. Patients with newly diagnosed diabetes were more likely ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... in hypertensive patients with diabetes mellitus and chronic heart failure are discussed. Special attention is paid ..." | ||
| Vol 8, No 1 (2012) | PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE | Abstract similar documents |
| M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova | ||
| "... to prevention of type 2 diabetes mellitus (DM). Data of international clinical trials shows that early GMD ..." | ||
| Vol 16, No 2 (2020) | Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study | Abstract similar documents |
| S. A. Shalnova, S. A. Maksimov, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, V. I. Tarasov, I. A. Viktorova, A. N. Redko, N. N. Prishchepa, S. S. Yakushin, O. M. Drapkina | ||
| "... in the elderly, in people with metabolic syndrome, hypertension or diabetes mellitus, as well as a history ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... Diabetes mellitus (DM) is one of the health and social problems of modern health care. The main ..." | ||
| Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
| "... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..." | ||
| Vol 19, No 1 (2023) | Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... The review article discusses the safety issue of anticoagulant therapy in elderly patients ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using ..." | ||
| Vol 6, No 3 (2010) | EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS | Abstract similar documents |
| S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva | ||
| "... in experimental diabetes mellitus. Materials and methods. Diabetes mellitus was induced by the administration ..." | ||
| Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
| V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
| "... on the salt sensitivity of hypertensive patients with diabetes mellitus type 2. Material and methods. 130 ..." | ||
| Vol 15, No 3 (2019) | Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus | Abstract similar documents |
| Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis | ||
| "... of type 2 diabetes mellitus. Material and methods. The study included patients with essential hypertension ..." | ||
| Vol 11, No 2 (2015) | DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES | Abstract similar documents |
| A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko | ||
| "... in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (DM) type 2 ..." | ||
| Vol 12, No 6 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract PDF (Eng) similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... ) in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 ..." | ||
| Vol 12, No 1 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... ) in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 ..." | ||
| Vol 18, No 3 (2022) | The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus | Abstract PDF (Eng) similar documents |
| O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov | ||
| "... in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (DM). Material and methods ..." | ||
| Vol 12, No 2 (2016) | THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES | Abstract similar documents |
| M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov | ||
| "... diabetes at high cardiovascular risk. ..." | ||
| Vol 15, No 6 (2019) | Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus | Abstract similar documents |
| A. V. Zhito, A. O. Iusupova, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov | ||
| "... The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes ..." | ||
| Vol 15, No 3 (2019) | Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders | Abstract similar documents |
| L. D. Khidirova, D. A. Yakhontov, S. A. Zenin, M. N. Mamedov | ||
| "... comorbid extracardiac diseases: diabetes mellitus (DM; n=40), diffuse toxic goiter (DTG; n=42 ..." | ||
| Vol 20, No 4 (2024) | The oxytocin-oxytocin receptors system — a new pathogenetic mechanism in the development of diabetic phenotype of heart failure with preserved ejection fraction in women | Abstract similar documents |
| A. D. Starchenko, Yu. V. Liskova, A. A. Stadnikov | ||
| "... (HFpEF) associated with type 2 diabetes mellitus (DM2T) (diabetic phenotype of HFpEF). Material ..." | ||
| Vol 9, No 3 (2013) | EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA) | Abstract similar documents |
| , , , , , , , , , , , | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... outcomes in patients with atherosclerosis and diabetes mellitus type 2 (DM2). Material and methods. 154 ..." | ||
| Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
| Vol 14, No 5 (2018) | Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting | Abstract similar documents |
| A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash | ||
| "... Aim. To assess the relationship between pre-diabetes/type 2 diabetes mellitus (type 2 DM ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term combined ..." | ||
| Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
| V. V. Fomin | ||
| "... resistance syndrome, diabetes type 2, dyslipidemia, obesity. Approaches to prevention of kidney disorder ..." | ||
| Vol 20, No 1 (2024) | Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome | Abstract similar documents |
| E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov | ||
| "... .8% of cases. Patients with no-/slow-reflow phenomenon more frequently had diabetes mellitus (42.4% vs. 22 ..." | ||
| Vol 5, No 3 (2009) | COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) | Abstract similar documents |
| Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova | ||
| "... ) and diabetes mellitus 2 type (DM2) and/or obesity. Material and methods. 592 patients: 176 men (29,7%) and 416 ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... with pleiotropic effect in patients with arterial hypertension and associated diseases (diabetes mellitus, obesity ..." | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 6, No 3 (2010) | CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| V. N. Larina, B. Ya. Bart, V. G. Larin | ||
| "... ,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... therapy (TAT), selection of P2Y12 inhibitor, choice of oral anticoagulant to be combined with antiplatelet ..." | ||
| 1 - 100 of 442 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
